Objective: To study the possibility of increasing the very long-chain n-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in humans by means of consumption of a common food product, Scandinavian caviar paste, suitable for strategic enrichment with a high concentration of these fatty acids, and to measure the potential inducement of lipid peroxidation. Design: A randomized double blind repeated measures experiment. Subjects and interventions: In total, 16 healthy, nonsmoking subjects (eight men and eight women, age 42712 y) were included in the study. Eight consumed 25 g ordinary caviar paste daily for 3 weeks, and eight the same amount of caviar paste enriched with a very stable fish oil (7%, wt/wt). Blood lipids, plasma phospholipid fatty acids and lipid peroxidation were measured. Results: a-Linoleic acid was significantly decreased after intake of both ordinary (À8%, Po0.05) and fish oil caviar (À10%, Po0.05), as was the sum of all n-6 fatty acids (À6%, Po0.05 and À8%, Po0.001, respectively). The fatty acids EPA and DHA, as well as the sum of all n-3 fatty acids, increased significantly in both caviar groups but more in the group given fish oil caviar paste (EPA: +51%, Po0.05 and +100%, Po0.001, respectively; DHA: +24%, Po0.01 and +29%, Po0.001, respectively; sum of n-3:+27%, Po0.05 and +40%, Po0.001, respectively). Lipid peroxidation, measured as the thiobarbituric acidFmalondialdehyde adduct, was increased by 26% (Po0.05) after intake of ordinary caviar paste, but was unchanged after intake of fish oil-enriched caviar paste. Conclusion: Scandinavian caviar paste is a spread naturally enriched with n-3 polyunsaturated fatty acids that can be included in the diet to achieve an increase in these fatty acids. However, changing to caviar paste enriched with stable fish oil will lead to a considerably greater increase in EPA and DHA.
Introduction
Since the discovery of the low incidence of ischemic heart disease among Eskimos (Bang & Dyerberg, 1980) , the scientific documentation of the beneficial effects of the long-chain n-3 polyunsaturated fatty acids found in seafood has grown rapidly, and today it is generally recommended that the intake of these disease-preventive fatty acids be increased. However, most Western societies consume little fish. Hence, an increase in fish consumption would involve major dietary changes, and has not proved to be an effective way to achieve an increase in the intake of these fatty acids (Mantzioris et al, 2000) . To take fish oil as a supplement is not an alternative at a community level. However, for a smaller population group on a therapeutic, clinical level, it can probably be a suitable way, especially if larger quantities need to be consumed. Another, more feasible alternative is strategic fish oil enrichment of suitable food products that are regularly consumed by a large part of the population.
In two earlier investigations, we studied the effect of fish oil introduced into bread, a food consumed by most people in large amounts, on some risk factors for ischemic heart disease (Saldeen et al, 1998; Liu et al, 2001) . In the present study, we have focused on another food suitable for enrichment, namely Scandinavian caviar paste.
Scandinavian caviar is a cod roe paste, usually smoked and mixed with vegetable oil and different spices, and has a long tradition as a popular spread on bread for all ages. Caviar paste is a good choice of food for enrichment with fish oil, as it already tastes partly of fish and can thus disguise the taste of the fish oil. Also, the high content of vegetable oil can partly be replaced by fish oil without affecting the consistency. This makes it possible to include a relatively large amount of fish oil. As it is a popular spread that is used by a large population, especially in the Scandinavian countries, it is suitable for enrichment with very long-chain n-3 polyunsaturated fatty acids.
In the present investigation, we have addressed the question of how the intake of ordinary caviar paste and of fish-oil-enriched caviar paste affects plasma phospholipid fatty acids and lipid peroxidation in normal subjects.
Materials and methods

Subjects and study design
The participants in the study were 16 healthy, nonsmoking volunteers (eight men and eight women), with a mean age of 42 y (range 26-65 y). Informed consent was obtained and the study was conducted in accordance with local ethical standards and the Declaration of Helsinki. The study was designed as a double-blind repeated measures experiment. The participants were randomly assigned in a blinded test to one of two groups, to receive ordinary caviar paste (Scandinavian caviar, cod roe paste) or fish oil-enriched caviar paste during a test period of 3 weeks. The ordinary caviar paste group consisted of eight subjects (three males, five females) with a mean age of 42712 y (range 30-58 y) and the fish oil-enriched caviar paste group consisted of eight subjects (five males, three females) with a mean age of 39712 y (range 26-65 y). Exclusion criteria were treatment for diseases, regular medication, nutritional supplements, pregnancy or obesity (body mass index (BMI) 430 kg/m 2 ). For additional pretreatment values of the two groups, see Tables 3 and 4 before intake of the caviar pastes. Blood samples were taken before and at the end of the test period. The intake of caviar was 25 g daily and the participants were carefully instructed as to how to apply the correct amount divided on two sandwiches. The amount corresponded to two 100 mm strings of caviar from the tube on each slice of bread, and is a reasonably normal amount when used as a spread.
The subjects were carefully instructed not to change their diets or their lifestyle during the experimental period. They were also instructed to refrain from alcohol consumption for 2 days and from vigorous physical activity for 1 day before the blood sampling. No acetylsalicylic acid (aspirin) or other nonsteroidal anti-inflammatory drugs were to be taken for at least 14 days before the sampling. None of the subjects had consumed fish oil previous to the study. Before blood sampling, the subjects had fasted for 10 h. The venous blood samples were always drawn at about 08:00 to minimize the effect of diurnal variation, without stasis and, after 15 min of rest, with the subject in the supine position. Plasma and serum were kept at À701C prior to the different analyses, with the exception of blood lipids and glucose, which were measured directly. The subjects were asked to bring the tubes with left-over caviar to the last blood sampling appointment. Compliance was assessed on the basis of reports from the subjects, the amount of caviar left after the treatment period, and by analyses of fatty acid composition in plasma phospholipids before and after the intervention period.
Fish oil and caviar composition
The fish oil (ESKIMO-3 Food, Cardinova AB, Sweden) is a natural and very stable fish oil. It is stabilized with a mixture of natural antioxidants (Pufanox s ) and contains 4.5 lU/g of vitamin E. It contains about 30% saturated fatty acids, 25% monounsaturated fatty acids and 45% polyunsaturated fatty acids in the form of triacylglycerols, as assayed by gas-liquid chromatography (Table 1) . Of the total fatty acids, 38% are of the n-3 type, 18% consist of eicosapentaenoic acid (20:5, EPA) and 12% consist of docosahexaenoic acid (22:6, DHA). The cholesterol concentration is less than 3 mg/g. The fish oil is very stable because of supplementation with the potent antioxidant mixture Pufanox s in a specific way. The peroxide value in the oil is o1 meq/kg and the anisidine value is o7, and after exposure to air for several months at room temperature the peroxide and anisidine values are still unchanged (Saldeen et al, 1999) . The stability of the oil has also been confirmed by an independent, commercial lipid analysis laboratory. During a specific step, the fish oil is cleared of undesirable compounds, such as environmental pollutants. All tested pollutants, such as dioxins, DDT, PCBs (polychlorinated biphenyls), and heavy metals (mercury, lead, cadmium), were below the detection levels (Jacobs & Johnston, 1995; Food Safety Authority of Ireland, 2002) .
The ordinary caviar was made of 65% cod roe paste (smoked) and 35% rapeseed oil (wt/wt), and in the fish oilenriched caviar 20% (wt/wt) of the rapeseed oil was replaced by fish oil. The fish oil caviar was produced by a Swedish caviar manufacturer (AB Boviks Konservfabrik, Lysekil, Sweden) and packed in tubes identical to those of the ordinary caviar in order to make it impossible for the participants to know which caviar type they were consuming. The fatty acid compositions of the rapeseed oil used in this preparation, the fish oil, the ordinary caviar and the fish oil-enriched caviar are shown in Table 2 . The amounts of EPA and DHA corresponding to 25 g of caviar intake were 0.11 and 0.18 g, respectively, for the ordinary caviar, and 0.45 and 0.39 g, respectively, for the fish-oil-enriched caviar (calculated from the free fatty acids with a conversion factor of 0.95 specified for Swedish caviar paste according to the Swedish National Food Administration tables of fatty acid content in foods (1998) and a fat content of the specific caviar paste of 36%). As shown in Table 2 , compared to the ordinary caviar, the fish-oil-enriched caviar had higher contents of saturated fatty acids (+31%), EPA (+75%) and DHA (+53%), and lower contents of oleic acid (À19%), linoleic acid (À25%) and a-linolenic acid (À21%). The sum of n-6 fatty acids was 22% lower and the sum of n-3 fatty acids was 30% higher in the fish oil-enriched caviar paste compared to the ordinary caviar.
Prior to this study, a blinded consumer sensory test was performed to find a suitable mixture of the fish oil and caviar (Meilgaard et al, 1991) .
Analyses of blood samples
Blood lipids and glucose were measured immediately after blood sampling, using routine enzymatic methods.
Lipoprotein (a) (Lp (a)) was determined by an enzyme immunoassay, TintElizet Lp(a) (Biopool AB, Umeå, Sweden), according to the manufacturer's instructions.
Lipoperoxides, generated in vivo as a result of oxygen freeradical-induced lipid peroxidation, were hydrolyzed, and the products, including malondialdehyde (MDA), were reacted with thiobarbituric acid (TBA) (Young & Trimble, 1991) . The formed MDA-(TBA) 2 adduct was measured by reversed-phase high-performance liquid chromatography (HPLC). The method used is described in detail by Wong et al (1987) ; however, a few modifications were made. To the plasma samples (2 ml) was added 20 ml butylated hydroxytoluene in ethanol (5%, w/v) immediately after blood sampling, in order to prevent the amplification of peroxidation during the assay (Chirico, 1994) . A TBA reaction was carried out by mixing phosphoric acid (750 ml, 0.15 M), plasma (500 ml) and TBA solution (250 ml, 42 mM). The reaction mixture was incubated in a boiling water bath for 60 min and then cooled in ice. In order to precipitate proteins and neutralize the solution, the samples (0.5 ml) were mixed with 0.5 ml sodium hydroxide (1 M)-methanol (9:91, v/v) and centrifuged (9000 Â g, 5 min, 41C). Since the MDA-(TBA) 2 adduct dissociates slowly at neutral or alkaline pH, this step was performed immediately prior to the HPLC run. MDA was calibrated with an 8 mM 1,1,3,3-tetraethoxypropan solution in 40% ethanol, which was diluted (40% ethanol) to different, suitable standard concentrations. The Gilson HPLC system used a Waters Nova-Pak s C18 (4 mm, 3.9 Â 150 mm) column fitted with a guard column (Waters Nova-Pak s C18, 4 mm, 3.9 Â 20 mm). The mobile phase consisted of methanol and potassium phosphate buffer (50 mM, pH 6.8) as a mixture (35:65, v/v) , and the flow rate was 1 ml/min and injection volume 20 ml. Detection was made using a UV/ visible detector set at 532 nm. The intra-assay precision was determined by analysis of a pooled plasma sample in multiplicate (n ¼ 4), and the interassay precision was determined for the same sample analyzed in multiple assays (n ¼ 3). The coefficients of variation were found to be 9 and 12%, respectively. The results are expressed as mM MDA equivalents.
Plasma plasminogen activator inhibitor-1 (PAI-1) was assayed amidolytically by means of COATEST s PAI (Kabi Diagnostica, Mölndahl, Sweden), using the chromogenic substrate S-2403. The color was read spectrophotometrically at 405 nm.
Plasma lipids were extracted with chloroform/methanol and submitted to thin-layer chromatography, and the phospholipids were subsequently recovered after evaluation of the plate. After hydrolysis and methylation, the fatty acid methyl esters were separated by gas-liquid chromatography as previously described (Boberg et al, 1985) .
Statistical methods
The SPSS 10.1 software package (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. An independent samples 
Results
The blinded consumer sensory test resulted in an enrichment with fish oil of 7% (wt/wt), with the rapeseed oil replaced by fish oil. With this degree of enrichment, the participants could not tell the difference between the two caviar types.
The results of the study are summarized in Figure 1 , Tables  3 and 4 . The pretreatment values did not differ significantly between the two groups. The changes in plasma phospholipid fatty acids observed after the treatment period showed the same tendencies with both ordinary and fish-oilenriched caviar paste (Figure 1) . Linoleic acid was significantly decreased after intake of both ordinary (À8%, Po0.05) and fish oil-enriched caviar paste (À10%, Po0.05), as was also the sum of all n-6 fatty acids (À6%, Po0.05 and À8%, Po0.001, respectively). Arachidonic acid, as well as alinolenic acid (18:3, n-3, not shown in table), remained unchanged in both cases. However, the n-3 fatty acids EPA and DHA, and the sum of all n-3 fatty acids, were significantly increased after the period both on ordinary and on fish oil-enriched caviar paste (EPA: +51%, Po0.05 and +100%, Po0.001, respectively; DHA: +24%, Po0.01 and +29%, Po0.001, respectively; sum of n-3: +27%, Po0.05 and +40%, Po0.001, respectively). After intake of caviar paste, the two groups differed significantly in DHA (Po0.05) and in the sum of n-3 fatty acids (Po0.05, Table 3 ). Figure 1 Fatty acid composition (% of total fatty acids) of plasma phospholipids before intake compared to after intake of ordinary and fish oilenriched caviar paste (7%, wt/wt; 25 g/day for 3 weeks). Data are expressed as mean7s.e. and n ¼ 8+8. *Po0.05, **Po0.01, ***Po0.001 compared to before treatment.
Effects of caviar paste enriched with fish oil on lipid peroxidation K Engström et al
No significant changes in blood lipids, glucose, Lp(a) or PAI-1 activity were observed except for a small increase in total serum cholesterol (+5%, Po0.05), serum HDL cholesterol (+10%, Po0.05) and serum LDL cholesterol (+10%, Po0.05) after intake of the fish oil-enriched caviar paste compared to before intake. The most sensitive marker of fish oil consumption, triacylglycerols, was decreased by 13% after intake of fish oil-enriched caviar paste and was increased by 8% after intake of ordinary caviar paste, but not significantly in either case (Table 4) .
Lipid peroxidation, measured as the MDA-(TBA) 2 adduct, showed a significant increase of 26% (Po0.05) after intake of the ordinary caviar paste, whereas after intake of the fish oilenriched caviar paste there was no significant change (Table 4) .
Discussion
The changes in plasma phospholipid fatty acids after intake of ordinary caviar paste and those after intake of fish oilenriched caviar paste ( Figure 1 and Table 3 ) followed the same direction, but the fish oil caviar paste had a more pronounced positive effect. The comparison between the two groups supports the trend towards a greater incorporation of n-3 fatty acids into phospholipids after intake of the fish oil-enriched compared to the ordinary caviar paste. The fish oil-enriched caviar contained 75% more of EPA and 53% more of DHA compared to the ordinary caviar (Table 2 ), but after intake of the fish oil-enriched caviar the plasma phospholipid EPA was 26% and DHA 18% higher compared to after intake of ordinary caviar. The differences in the content of EPA and DHA in the two caviar types are reflected in comparable equal increases after intake. However, despite the higher amount of DHA than EPA in the ordinary caviar, the increase in plasma phospholipid EPA after intake was higher than the increase in DHA. This was also experienced by Mantzioris et al (2000) when examining the effectiveness of a diet containing foods enriched with n-3 polyunsaturated fatty acids. This can possibly be explained by the high content of a-linolenic acid, which increases tissue EPA but Table 3 Fatty acid composition (% of total fatty acids) of plasma phospholipids before intake compared to after intake of ordinary caviar paste and fish oil-enriched caviar paste (7%, wt/wt; 25 g/day for 3 weeks), and a comparison between the groups after intake After intake compared to before intake. b After fish-oil-enriched caviar paste intake compared to after ordinary caviar paste intake. Effects of caviar paste enriched with fish oil on lipid peroxidation K Engström et al not DHA (Sanders & Younger, 1981; Mantzioris et al, 1994) . The fish oil-enriched caviar paste contained both less alinolenic acid than the ordinary caviar, and more EPA than DHA (Table 2) , but probably a part of the increase in EPA also results from an a-linolenic acid conversion. The conversion of EPA to DHA can also go the other way from DHA to EPA (Tocher & Dick, 2001 ) and it might be preferable with a high EPA content in the food since it can probably slow down this reversible conversion which leads to a decreasing DHA content.
The pretreatment values did not differ significantly between the two groups (Table 4) , although the mean MDA and HDL cholesterol levels in the fish oil-enriched caviar paste group were somewhat lower than in the ordinary caviar group, and the opposite was true for Lp(a). This difference is probably due to the limited number of participants in each group (n ¼ 8). In this study, we found a small but significant increase in total serum cholesterol, serum HDL cholesterol and serum LDL cholesterol after intake of the fish oil-enriched caviar paste compared to before intake (Table 4 ). This is in contrast to Haglund et al (1990) , who reported a significant decrease in cholesterol and triacylglycerol concentrations to occur after 3 months in healthy subjects taking a large dose (14 g) of fish oil daily. In subjects with hyperlipidemia, Liu et al (2001) observed a significant increase in HDL cholesterol and decrease in triacylglycerols after 4 weeks but not 2 weeks, after intake of fish oil-enriched bread containing a small amount of fish oil.
The concentration of MDA in plasma was measured by an isocratic HPLC method, essentially as described previously (Wong et al, 1987) . This method is simple and achieves excellent separation of the MDA-(TBA) 2 adduct from contaminants. However, a small amount of free MDA might be found in plasma, apart from the MDA generated by decomposition of lipid hydroperoxides during the acidheating stage, as well as the MDA that is formed during prostaglandin metabolism, but these contributions are very small (Chirico, 1994) . The mean concentration and range of plasma MDA were similar to those reported from other studies (Wong et al, 1987; Young & Trimble, 1991) . Plasma MDA increased significantly after intake of ordinary caviar paste (Table 4) , an effect that might have been caused by the natural high content of n-3 polyunsaturated fatty acids. If the caviar, for some reason, was not stable enough, or if lipid peroxidation was initiated during production or handling, this might have resulted in an increased in vivo lipid peroxidation after ingestion. We have no data on the stability of the ordinary caviar paste or the fish oil-enriched, except for the fish oil included. The addition of the antioxidant mixture Pufanox s (included in the fish oil used) into the enriched caviar paste might have terminated an ongoing lipid peroxidation process, leading to less in vivo lipid peroxidation after ingestion despite the higher content of EPA and DHA. Concerns have been raised about the oxidative stress that can result from increased intakes of n-3 polyunsaturated fatty acids (Kris-Etherton et al, 2000; Sanders, 2000) . There are some studies in humans concerning lipid peroxidation in plasma or LDL after intake of fish oils, using both high (Higdon et al, 2000 (Higdon et al, , 2001 and low doses of fish oil (Higgins et al, 2001) . None of these studies found an increased lipid peroxidation. On the contrary, there are also some studies using modified fish oil, which report of an increased lipid peroxidation as well as adverse effects (Johansen et al, 1999; Stalenhoef et al, 2000) . Haglund et al (1991) reported on differences in plasma MDA after intake of large doses of fish oils containing different amounts of vitamin E. Stability measurements of the fish oils used (eg peroxide and anisidine values before and after storage in standardized settings, Frankel, 1998) are, however, not provided in these studies. The correlation between intake of unstable fish oils or enriched products with in vivo lipid peroxidation in humans needs more investigation.
According to the blinded consumer sensory test, the fish oil-enriched caviar did not taste different from the ordinary caviar. The taste of the ordinary caviar was a good disguise for the fish oil, and a relatively large amount of fish oil could therefore be included. The amount of caviar paste consumed daily (25 g) was equivalent to a normal amount of spread used on two sandwiches, and was chosen to reflect a realistic consumption.
In Sweden, fish oil has recently been introduced into other types of food, for example margarine spread (Gaio, Arla, Götene, Sweden) and bread (LEVA, Pågens, Malmö, Sweden). Two slices of this bread (62 g) would provide 0.24 g of EPA+DHA. If the margarine spread (10 g) was used on these two slices, it would add 0.06 g of EPA+DHA. If fish oilenriched caviar paste was used (25 g) on top of this, an extra 0.84 g of EPA+DHA would be included, giving a total intake of 1.14 g EPA+DHA. The fish oil-enriched caviar would then account for 74% of all EPA+DHA included in the two sandwiches, whereas the margarine spread would only account for 5%. For comparison, a meal of cod (100 g) would give 0.2 g of EPA+DHA and a meal of salmon (100 g) would give 1.8 g of EPA+DHA (National Food Administration, 1998) . In Sweden, as in many Western countries, the intake of fish has decreased considerably in the last century. If four meals of cod and four meals of salmon were consumed in a month, together with only one fish oil-enriched caviar paste sandwich (as described above) daily, the total intake of EPA+DHA would be 8.0 g (0.27 g/day) from the fish meals and 17.1 g (0.57 g/day) from the caviar sandwich, the latter then accounting for 68% of the total intake. Even if a smaller number of enriched sandwiches were consumed, the intake of EPA+DHA would still make a big difference to a diet poor in seafood.
There are not many recommendations on fatty acid intakes that specify EPA and DHA, and they also vary considerably. However, a group of nutrition scientists has recently provided guidelines for specific recommendations for adequate intakes (AI) of EPA and DHA (Simopolous et al, 1999) , which has also been used by Kris-Etherton et al (2000) as a target for EPA and DHA increase in the US diet. This group suggests that intake of EPA and DHA combined should be 0.65 g/day (on a 2000 kcal diet, or 0.3% of energy). In addition, they also recommend an intake of a-linolenic acid of 2.2 g/day and an upper limit of linoleic acid of 6.7 g/day. The intake of only one fish oil-enriched caviar paste sandwich daily will be almost sufficient to meet the recommendations concerning EPA and DHA.
All possible ways of increasing the amount of EPA and DHA in populations characterized by a low fish intake must be encouraged, since evidence from the vast and fastgrowing scientific research indicates that these fatty acids play a crucial role in the prevention or improvement of many different diseases, including ischemic heart disease. To offer strategically enriched foods, like this fish oil-enriched caviar paste, alongside ordinary products on the shelves is one way among others. However, the population would have to be made aware of the benefits of actively choosing these specific products, and of most probably paying a higher price for them.
In conclusion, Scandinavian caviar paste is a spread that is naturally enriched with EPA and DHA, and can be included in the diet to achieve a desired increase in these fatty acids. Furthermore, since caviar paste is a very suitable food for supplementation with a relatively large amount of fish oil, the use of this strategically enriched caviar can produce a considerable increase in the concentrations of EPA and DHA. More research is warranted concerning the oxidative stress that can result from increased intake of n-3 polyunsaturated fatty acids as well as concerning a possible induction of lipid peroxidation during production and storage of enriched foods.
